Improving the Transition to Palliative Care for Patients With Acute Leukemia: A Coordinated Care Approach

Bianca Hopkins, Michelle Gold, Andrew Wei, George Grigoriadis

Research output: Contribution to journalArticleResearchpeer-review

Abstract

BACKGROUND:: Currently, there is little guidance available for documenting and executing the change in management goals in the context of incurable hematologic disease. OBJECTIVE:: The aim of this study was to improve the transition to palliative care for patients with acute myeloid leukemia (AML) through the development and implementation of a coordinated care plan program. METHODS:: Twenty-three patients with AML who were no longer being treated with curative intent from March 2011 through September 2012 had hematology supportive care plans developed. Patients (n = 7) completed post–care plan implementation questionnaires to determine their level of understanding in relation to the change in treatment intent. Staff completed pre– (n = 26) and post– (n = 19) care plan implementation questionnaires to determine the communication, challenges, and accessibility of changed management goals. RESULTS:: Seventy-seven percent of patients understood palliative care to be the primary team managing their symptoms, with 75% of patients viewing symptom control as the main goal of treatment. Staff findings demonstrated a significant improvement in the communication of treatment goals (53% preimplementation vs 86% postimplementation). Early timing of referrals remains a significant issue. CONCLUSIONS:: Implementing the individualized care plan program was associated with better communication and accessibility of documented palliative treatment goals for patients with AML. IMPLICATIONS FOR PRACTICE:: This study establishes a model of care that addresses symptom and disease burden in end-stage AML and provides valuable insight into the patient and family understanding of treatment intent during this terminal phase.

Original languageEnglish
Pages (from-to)E17-E23
Number of pages7
JournalCancer Nursing
Volume40
Issue number3
DOIs
Publication statusPublished - May 2017

Cite this

@article{d7ddfa9b42b042359089d0d8957aa3c6,
title = "Improving the Transition to Palliative Care for Patients With Acute Leukemia: A Coordinated Care Approach",
abstract = "BACKGROUND:: Currently, there is little guidance available for documenting and executing the change in management goals in the context of incurable hematologic disease. OBJECTIVE:: The aim of this study was to improve the transition to palliative care for patients with acute myeloid leukemia (AML) through the development and implementation of a coordinated care plan program. METHODS:: Twenty-three patients with AML who were no longer being treated with curative intent from March 2011 through September 2012 had hematology supportive care plans developed. Patients (n = 7) completed post–care plan implementation questionnaires to determine their level of understanding in relation to the change in treatment intent. Staff completed pre– (n = 26) and post– (n = 19) care plan implementation questionnaires to determine the communication, challenges, and accessibility of changed management goals. RESULTS:: Seventy-seven percent of patients understood palliative care to be the primary team managing their symptoms, with 75{\%} of patients viewing symptom control as the main goal of treatment. Staff findings demonstrated a significant improvement in the communication of treatment goals (53{\%} preimplementation vs 86{\%} postimplementation). Early timing of referrals remains a significant issue. CONCLUSIONS:: Implementing the individualized care plan program was associated with better communication and accessibility of documented palliative treatment goals for patients with AML. IMPLICATIONS FOR PRACTICE:: This study establishes a model of care that addresses symptom and disease burden in end-stage AML and provides valuable insight into the patient and family understanding of treatment intent during this terminal phase.",
author = "Bianca Hopkins and Michelle Gold and Andrew Wei and George Grigoriadis",
year = "2017",
month = "5",
doi = "10.1097/NCC.0000000000000368",
language = "English",
volume = "40",
pages = "E17--E23",
journal = "Cancer Nursing",
issn = "0162-220X",
publisher = "Lippincott Williams & Wilkins",
number = "3",

}

Improving the Transition to Palliative Care for Patients With Acute Leukemia : A Coordinated Care Approach. / Hopkins, Bianca; Gold, Michelle; Wei, Andrew; Grigoriadis, George.

In: Cancer Nursing, Vol. 40, No. 3, 05.2017, p. E17-E23.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Improving the Transition to Palliative Care for Patients With Acute Leukemia

T2 - A Coordinated Care Approach

AU - Hopkins, Bianca

AU - Gold, Michelle

AU - Wei, Andrew

AU - Grigoriadis, George

PY - 2017/5

Y1 - 2017/5

N2 - BACKGROUND:: Currently, there is little guidance available for documenting and executing the change in management goals in the context of incurable hematologic disease. OBJECTIVE:: The aim of this study was to improve the transition to palliative care for patients with acute myeloid leukemia (AML) through the development and implementation of a coordinated care plan program. METHODS:: Twenty-three patients with AML who were no longer being treated with curative intent from March 2011 through September 2012 had hematology supportive care plans developed. Patients (n = 7) completed post–care plan implementation questionnaires to determine their level of understanding in relation to the change in treatment intent. Staff completed pre– (n = 26) and post– (n = 19) care plan implementation questionnaires to determine the communication, challenges, and accessibility of changed management goals. RESULTS:: Seventy-seven percent of patients understood palliative care to be the primary team managing their symptoms, with 75% of patients viewing symptom control as the main goal of treatment. Staff findings demonstrated a significant improvement in the communication of treatment goals (53% preimplementation vs 86% postimplementation). Early timing of referrals remains a significant issue. CONCLUSIONS:: Implementing the individualized care plan program was associated with better communication and accessibility of documented palliative treatment goals for patients with AML. IMPLICATIONS FOR PRACTICE:: This study establishes a model of care that addresses symptom and disease burden in end-stage AML and provides valuable insight into the patient and family understanding of treatment intent during this terminal phase.

AB - BACKGROUND:: Currently, there is little guidance available for documenting and executing the change in management goals in the context of incurable hematologic disease. OBJECTIVE:: The aim of this study was to improve the transition to palliative care for patients with acute myeloid leukemia (AML) through the development and implementation of a coordinated care plan program. METHODS:: Twenty-three patients with AML who were no longer being treated with curative intent from March 2011 through September 2012 had hematology supportive care plans developed. Patients (n = 7) completed post–care plan implementation questionnaires to determine their level of understanding in relation to the change in treatment intent. Staff completed pre– (n = 26) and post– (n = 19) care plan implementation questionnaires to determine the communication, challenges, and accessibility of changed management goals. RESULTS:: Seventy-seven percent of patients understood palliative care to be the primary team managing their symptoms, with 75% of patients viewing symptom control as the main goal of treatment. Staff findings demonstrated a significant improvement in the communication of treatment goals (53% preimplementation vs 86% postimplementation). Early timing of referrals remains a significant issue. CONCLUSIONS:: Implementing the individualized care plan program was associated with better communication and accessibility of documented palliative treatment goals for patients with AML. IMPLICATIONS FOR PRACTICE:: This study establishes a model of care that addresses symptom and disease burden in end-stage AML and provides valuable insight into the patient and family understanding of treatment intent during this terminal phase.

UR - http://www.scopus.com/inward/record.url?scp=84962077686&partnerID=8YFLogxK

U2 - 10.1097/NCC.0000000000000368

DO - 10.1097/NCC.0000000000000368

M3 - Article

VL - 40

SP - E17-E23

JO - Cancer Nursing

JF - Cancer Nursing

SN - 0162-220X

IS - 3

ER -